Sympathoinhibitory function of the α2A-adrenergic receptor subtype

被引:62
|
作者
Makaritsis, KP
Johns, C
Gavras, I
Altman, JD
Handy, DE
Bresnahan, MR
Gavras, H
机构
[1] Boston Univ, Sch Med, Hyperts & Atherosclerosis Sect, Boston, MA 02118 USA
[2] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA
关键词
adrenergic receptors; mice; knockout; hypertension; sodium-dependent; hyperadrenergic state;
D O I
10.1161/01.HYP.34.3.403
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Presynaptic alpha(2)-adrenergic receptors (alpha(2)-AR) are distributed throughout the central nervous system and are highly concentrated in the brain stem, where they contribute to neural baroreflex control of blood pressure (BP). To explore the role of the alpha(2A)-AR subtype in this function, we compared BP and plasma norepinephrine and epinephrine levels in genetically engineered mice with deleted alpha(2A)-AR gene to their wild-type controls. At baseline, the alpha(2A)-AR gene knockouts (n=11) versus controls (n=10) had higher systolic BP (123+/-2.5 versus 115+/-2.5 mm Hg, P<0.05), heart rate (730+/-15 versus 600+/-18 b/min, P<0.001), and norepinephrine (1.005+/-0.078 versus 0.587+/-0.095 ng/mL, P<0.01), respectively. When submitted to subtotal nephrectomy and given 1% saline as drinking water, both alpha(2A)-AR gene knockouts (n=14) and controls (n=14) became hypertensive, but the former required 15.6+/-2.5 days versus 29.3+/-1.4 days for the controls (P<0.001). End-point systolic BP was similar for both at 155+/-2.1 versus 152+/-5.2 mm Hg, but norepinephrine and epinephrine levels were twice as high in the knockouts at 1.386+/-0.283 and 0.577+/-0.143 versus 0.712+/-0.110 and 0.255+/-0.032 ng/mL, respectively, P<0.05 for both; We conclude that the alpha(2A)-AR subtype exerts a sympathoinhibitory effect, and its loss leads to a hypertensive, hyperadrenergic state.
引用
收藏
页码:403 / 407
页数:5
相关论文
共 50 条
  • [31] α2A-Adrenergic Receptors and Type 2 Diabetes
    Gribble, Fiona M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (04): : 361 - 362
  • [32] Polymorphism of the α2A-adrenergic receptor gene and epinephrine-induced platelet aggregation
    Afshar-Kharghan, V
    Sun, C
    Zhang, H
    Wood, J
    Leal, S
    Dong, JF
    Bray, PF
    BLOOD, 2004, 104 (11) : 437A - 437A
  • [33] Association of α2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females
    Fulcutake, Masaaki
    Hishimoto, Akitoyo
    Nishiguchi, Naoki
    Nushida, Hideyuki
    Ueno, Yasuhiro
    Shirakawa, Osamu
    Maeda, Kiyoshi
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06): : 1428 - 1433
  • [34] Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist
    Tang, Yunzhao
    Axelsson, Annika S.
    Spegel, Peter
    Andersson, Lotta E.
    Mulder, Hindrik
    Groop, Leif C.
    Renstrom, Erik
    Rosengren, Anders H.
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (257)
  • [35] The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran
    Wakeno, Masataka
    Kato, Masaki
    Okugawa, Gaku
    Fukuda, Tsuyoshi
    Hosoi, Yuka
    Takekita, Yoshiteru
    Yamashita, Megumi
    Nonen, Shinpei
    Azuma, Junichi
    Kinoshita, Toshihiko
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (05) : 518 - 524
  • [36] Abnormal regulation of the sympathetic nervous system in α2A-adrenergic receptor knockout mice
    Altman, JD
    Trendelenburg, AU
    Macmillan, L
    Bernstein, D
    Limbird, L
    Starke, K
    Kobilka, BK
    Hein, L
    MOLECULAR PHARMACOLOGY, 1999, 56 (01) : 154 - 161
  • [37] Role of hippocampal α2A-adrenergic receptor in methamphetamine-induced hyperlocomotion in the mouse
    Nishio, M
    Kuroki, Y
    Watanabe, Y
    NEUROSCIENCE LETTERS, 2003, 341 (02) : 156 - 160
  • [38] Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor
    Fink, Elissa A.
    Xu, Jun
    Huebner, Harald
    Braz, Joaom.
    Seemann, Philipp
    Avet, Charlotte
    Craik, Veronica
    Weikert, Dorothee
    Schmidt, Maximilian F.
    Webb, Chase M.
    Tolmachova, Nataliya A.
    Moroz, Yurii S.
    Huang, Xi-Ping
    Kalyanaraman, Chakrapani
    Gahbauer, Stefan
    Chen, Geng
    Liu, Zheng
    Jacobson, Matthew P.
    Irwin, John J.
    Bouvier, Michel
    Du, Yang
    Shoichet, Brian K.
    Basbaum, Allan I.
    Gmeiner, Peter
    SCIENCE, 2022, 377 (6614) : 1509 - +
  • [39] Characterization of the allosteric interactions between antagonists and amiloride analogues at the human α2A-adrenergic receptor
    Leppik, RA
    Lazareno, S
    Mynett, A
    Birdsall, NJM
    MOLECULAR PHARMACOLOGY, 1998, 53 (05) : 916 - 925
  • [40] 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling
    Dinter, Juliane
    Muehlhaus, Jessica
    Jacobi, Simon Friedrich
    Wienchol, Carolin Leonie
    Coester, Maxi
    Meister, Jaroslawna
    Hoefig, Carolin Stephanie
    Mueller, Anne
    Koehrle, Josef
    Grueters, Annette
    Krude, Heiko
    Mittag, Jens
    Schoeneberg, Torsten
    Kleinau, Gunnar
    Biebermann, Heike
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2015, 54 (03) : 205 - 216